NC6
NANOLLOSE LIMITED
$0.0770
0.00%
Market cap
$32M
Turnover
$1
Last price
$0.0770
Day change
0.00%
Announcements
3
Range, past year
Open 0.052 · Low 0.028 · Now 0.077 · High 0.085
Open NC6 in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
NC6 momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
23/100
Wyckoff phase
Distribution5d
Trend stage
Emerging
1 Day
+0.0%
1 Week
+13.2%
1 Month
-3.8%
1 Year
+45.3%
RSI
55
Avg daily range
3.3%
NANOLLOSE LIMITED scores 23 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Distribution, where it has been for 5 trading days. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- RSI in healthy zone (55)
Points to watch
- Thin liquidity
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsNC6 announcements
Recent price-sensitive releases.
- 2026-08-31 Appendix 4E & Annual Report to shareholders Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-04-30 Quarterly Activities/Appendix 4C Cash Flow Report
More Health Care stocks
Most traded in the same sector.